13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-09-17 Event — SEC 0001957912-26-000030 →

Baselake Partners, LP KIORA PHARMACEUTICALS, INC. KPHMW

Stake: Shares: Class: Common Stock, $0.01 par value

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
1 transaction
1 buys · 0 sales · 0 awards/exercises
Issuer Cluster
9 13D/G filings on this issuer
8 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest
Not in latest FINRA snapshot

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-09-17 Lane Keith J. Award 55,000 $2.67 $147K

Other 13D/G Filings on KIORA PHARMACEUTICALS, INC.

FiledFormFilerStakeShares
2021-08-03 SC ARMISTICE CAPITAL, LLC view →
2021-01-12 SC ARMISTICE CAPITAL, LLC view →
2020-01-15 SC ARMISTICE CAPITAL, LLC view →
2019-10-18 SC ARMISTICE CAPITAL, LLC view →
2019-10-02 SC ARMISTICE CAPITAL, LLC view →
2019-04-04 SC ARMISTICE CAPITAL, LLC view →
2018-01-17 SC IPSA (INNOVEN PARTENAIRES S.A.) view →
2018-01-02 SC IPSA (INNOVEN PARTENAIRES S.A.) view →

Other Filings by Baselake Partners, LP

FiledFormIssuerStakeShares
2026-06-25 SCHEDULE 13G Passage Bio, Inc. PASG view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →